<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=11930&amp;modal=1&amp;valnames=arms&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="285073" class="table-">
                
                <td>Nov. 26, 2021, 10:30 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Intervention1: INTRAVENOUS HIGH DOSE DEXAMETHASONE (20MG): Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly high dose dexamethasone (20mg) will be administered for 3 days. This will be followed by the regular institutional protocol of 6mg dexamethasone once a day.Intervention2: Tocilizumab 400mg: Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly injection tociliziumab (6mg/kg) maximum of 480mg will be administered.A single repeat dose may be considered if there is no improvement or clinical worsening in next 24 hours. This will be in addition to the regular 6mg dexamethasone as per institutional protocol.Control Intervention1: Not applicable: Not applicable&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Intervention1: INTRAVENOUS HIGH DOSE DEXAMETHASONE (20MG): Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly high dose dexamethasone (20mg) will be administered for 3 days. This will be followed by the regular institutional protocol of 6mg dexamethasone once a day.&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Intervention2: Tocilizumab 400mg: Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly injection tociliziumab (6mg/kg) maximum of 480mg will be administered.A single repeat dose may be considered if there is no improvement or clinical worsening in next 24 hours. This will be in addition to the regular 6mg dexamethasone as per institutional protocol.&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Intervention1: Not applicable: Not applicable&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 400, &quot;treatment_name&quot;: &quot;Dexamethasone&quot;, &quot;treatment_type&quot;: &quot;Corticosteroids&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 1299, &quot;treatment_name&quot;: &quot;Tocilizumab&quot;, &quot;treatment_type&quot;: &quot;Interleukin inhibitors&quot;, &quot;pharmacological_treatment&quot;: &quot;Pharmacological treatment&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="276137" class="table-">
                
                <td>Nov. 13, 2021, 5:33 p.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;N/A&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="250479" class="table-">
                
                <td>May 27, 2021, 12:45 a.m.</td>
                <td>oms</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Intervention1: INTRAVENOUS HIGH DOSE DEXAMETHASONE (20MG): Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly high dose dexamethasone (20mg) will be administered for 3 days. This will be followed by the regular institutional protocol of 6mg dexamethasone once a day.Intervention2: Tocilizumab 400mg: Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly injection tociliziumab (6mg/kg) maximum of 480mg will be administered.A single repeat dose may be considered if there is no improvement or clinical worsening in next 24 hours. This will be in addition to the regular 6mg dexamethasone as per institutional protocol.Control Intervention1: Not applicable: Not applicable&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Intervention1: INTRAVENOUS HIGH DOSE DEXAMETHASONE (20MG): Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly high dose dexamethasone (20mg) will be administered for 3 days. This will be followed by the regular institutional protocol of 6mg dexamethasone once a day.&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Intervention2: Tocilizumab 400mg: Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly injection tociliziumab (6mg/kg) maximum of 480mg will be administered.A single repeat dose may be considered if there is no improvement or clinical worsening in next 24 hours. This will be in addition to the regular 6mg dexamethasone as per institutional protocol.&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;Control Intervention1: Not applicable: Not applicable&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
        </tbody>
    </table>
</div>
Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: INTRAVENOUS HIGH DOSE DEXAMETHASONE (20MG): Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly high dose dexamethasone (20mg) will be administered for 3 days. This will be followed by the regular institutional protocol of 6mg dexamethasone once a day.Intervention2: Tocilizumab 400mg: Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly injection tociliziumab (6mg/kg) maximum of 480mg will be administered.A single repeat dose may be considered if there is no improvement or clinical worsening in next 24 hours. This will be in addition to the regular 6mg dexamethasone as per institutional protocol.Control Intervention1: Not applicable: Not applicable", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: INTRAVENOUS HIGH DOSE DEXAMETHASONE (20MG): Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly high dose dexamethasone (20mg) will be administered for 3 days. This will be followed by the regular institutional protocol of 6mg dexamethasone once a day.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: Tocilizumab 400mg: Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly injection tociliziumab (6mg/kg) maximum of 480mg will be administered.A single repeat dose may be considered if there is no improvement or clinical worsening in next 24 hours. This will be in addition to the regular 6mg dexamethasone as per institutional protocol.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Not applicable: Not applicable", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 400, "treatment_name": "Dexamethasone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]
Nov. 13, 2021, 5:33 p.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]
May 27, 2021, 12:45 a.m.	oms	[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: INTRAVENOUS HIGH DOSE DEXAMETHASONE (20MG): Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly high dose dexamethasone (20mg) will be administered for 3 days. This will be followed by the regular institutional protocol of 6mg dexamethasone once a day.Intervention2: Tocilizumab 400mg: Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly injection tociliziumab (6mg/kg) maximum of 480mg will be administered.A single repeat dose may be considered if there is no improvement or clinical worsening in next 24 hours. This will be in addition to the regular 6mg dexamethasone as per institutional protocol.Control Intervention1: Not applicable: Not applicable", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: INTRAVENOUS HIGH DOSE DEXAMETHASONE (20MG): Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly high dose dexamethasone (20mg) will be administered for 3 days. This will be followed by the regular institutional protocol of 6mg dexamethasone once a day.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: Tocilizumab 400mg: Following admission in the COVID ICU; standard treatment according to the COVID management institutional protocol will be done. If there is deterioration or worsening of the patient status; block randomisation will be done and accordingly injection tociliziumab (6mg/kg) maximum of 480mg will be administered.A single repeat dose may be considered if there is no improvement or clinical worsening in next 24 hours. This will be in addition to the regular 6mg dexamethasone as per institutional protocol.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Not applicable: Not applicable", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]